North America Oxygen Concentrators Market To Reach $1.9 Billion By 2030

North America Oxygen Concentrators Market Growth & Trends

The North America oxygen concentrators market size is anticipated to reach USD 1.9 billion by 2030 and is projected to grow at a CAGR of 5.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market's growth is driven by various factors, such as advanced product offerings, expanding business operations, increasing respiratory disease incidence, and a rising preference for home-based oxygen therapy. For instance, in May 2022, Sanrai International's collaboration with Drive DeVilbiss resulted in the launch of the 1060AW 10L Stationary Oxygen Concentrator, highlighting the industry's commitment to innovation. Moreover, the market is poised to benefit from the growing demand for portable oxygen concentrators, which have seen a significant increase in adoption. From 2015 to 2021, the U.S. market witnessed a rise in portable oxygen concentrator penetration from 8% to 22%, as per U.S. Medicare claims data. This trend is expected to drive market growth in the forecast period.

The COVID-19 pandemic had a limited positive impact on the regional market. Due to the surge in hospitalizations, medical facilities faced challenges in providing respiratory support to critically ill patients due to the limited availability of ventilators. As a result, the demand for oxygen concentrators as an alternative solution increased.

The government initiatives to raise patient awareness have contributed to market growth. For instance, in June 2021, the U.S. government, through the U.S. Agency for International Development (USAID), donated 50 oxygen concentrators to Haiti to combat the COVID-19 pandemic. This contribution aligns with broader initiatives to enhance the medical infrastructure and provide advanced technology and oxygen equipment to support healthcare in Haiti.

Notable players in the industry, such as Inogen are implementing strategic initiatives to expand their product offerings and reach. These initiatives include acquisitions, collaborations, expansions, and new product launches. For instance, Inogen announced in a press release in January 2023 that the company received clearance from the U.S.FDA for their new portable oxygen concentrator, Rove 4, on December 9, 2022. This advancement would further solidify Inogen's position in portable oxygen concentrators market. 

 Request a free sample copy or view report summary: North America Oxygen Concentrators Market Report

North America Oxygen Concentrators Market Report Highlights

• The portable medical oxygen concentrators (POCs) segment led the market with the largest revenue share of 54.8% in 2023. This dominance is owing to the large number of benefits associated with POCs

• Based on application, the home care segment led the market with the largest revenue share of 66.7% in 2023. The key factors responsible for the dominance are the increasing demand for home healthcare therapies and changing patients’ preferences for comfortable and convenient therapy

• Based on technology, the continuous flow technology segment led the market with the largest revenue share of 61.6% in 2023, owing to rapid technological advancements and the rising number of patients suffering from respiratory disorders 

North America Oxygen Concentrators Market Segmentation

Grand View Research has segmented the North America oxygen concentrators market report based on product, application, technology, and region: 

North America Oxygen Concentrators Product outlook (Revenue, USD Billion, 2018 - 2030)

• Portable Medical Oxygen Concentrators

• Fixed Medical Oxygen Concentrators

North America Oxygen Concentrators Application outlook (Revenue, USD Billion, 2018 - 2030)

• Home Care

• Non- Home Care

North America Oxygen Concentrators Technology outlook (Revenue, USD Billion, 2018 - 2030)

• Continuous Flow

• Pulse Flow

North America Oxygen Concentrators Country Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.

  • Canada 

Key Players in North America Oxygen Concentrators Market

• Inogen, Inc.

• Respironics (a subsidiary of Koninklijke Philips N.V.) {Effective from January 25, 2024, Philips Respironics halted the sale of their POCs, with end of service scheduled for January 25, 2029.}

• React Health (Respiratory Product Line from Invacare Corporation)

• Caire Medical (Acquired by Niterra Co., Ltd. formerly known as NGK SPARK PLUG CO., LTD.)

• DeVilbiss Healthcare (a subsidiary of Drive Medical)

• O2 Concepts

• Nidek Medical Products, Inc

• GCE

• Rhythm Healthcare

• MedaCure Inc.

• GF Health Products, Inc.

• Direct Supply

• Compass Health Brands